vs

Side-by-side financial comparison of Claritev Corp (CTEV) and Orion S.A. (OEC). Click either name above to swap in a different company.

Orion S.A. is the larger business by last-quarter revenue ($411.7M vs $246.6M, roughly 1.7× Claritev Corp). On growth, Claritev Corp posted the faster year-over-year revenue change (6.2% vs -5.2%). Orion S.A. produced more free cash flow last quarter ($44.2M vs $36.4M). Over the past eight quarters, Claritev Corp's revenue compounded faster (2.5% CAGR vs -9.5%).

Orion Corporation, founded in 1917 and headquartered at Espoo, Finland, is a globally operating Finnish company which develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients for global markets. All of the company's manufacturing sites and the majority of its R&D units are in Finland.

CTEV vs OEC — Head-to-Head

Bigger by revenue
OEC
OEC
1.7× larger
OEC
$411.7M
$246.6M
CTEV
Growing faster (revenue YoY)
CTEV
CTEV
+11.4% gap
CTEV
6.2%
-5.2%
OEC
More free cash flow
OEC
OEC
$7.8M more FCF
OEC
$44.2M
$36.4M
CTEV
Faster 2-yr revenue CAGR
CTEV
CTEV
Annualised
CTEV
2.5%
-9.5%
OEC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CTEV
CTEV
OEC
OEC
Revenue
$246.6M
$411.7M
Net Profit
$-80.6M
Gross Margin
18.9%
Operating Margin
-3.1%
4.3%
Net Margin
-32.7%
Revenue YoY
6.2%
-5.2%
Net Profit YoY
41.6%
EPS (diluted)
$-4.88
$-0.36

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CTEV
CTEV
OEC
OEC
Q4 25
$246.6M
$411.7M
Q3 25
$246.0M
$450.9M
Q2 25
$241.6M
$466.4M
Q1 25
$231.3M
$477.7M
Q4 24
$232.1M
$434.2M
Q3 24
$230.5M
$463.4M
Q2 24
$233.5M
$477.0M
Q1 24
$234.5M
$502.9M
Net Profit
CTEV
CTEV
OEC
OEC
Q4 25
$-80.6M
Q3 25
$-69.8M
$-67.1M
Q2 25
$-62.6M
$9.0M
Q1 25
$-71.3M
$9.1M
Q4 24
$-138.0M
Q3 24
$-391.4M
$-20.2M
Q2 24
$-576.7M
$20.5M
Q1 24
$-539.7M
$26.7M
Gross Margin
CTEV
CTEV
OEC
OEC
Q4 25
18.9%
Q3 25
19.0%
Q2 25
21.1%
Q1 25
20.5%
Q4 24
20.6%
Q3 24
23.2%
Q2 24
23.0%
Q1 24
24.3%
Operating Margin
CTEV
CTEV
OEC
OEC
Q4 25
-3.1%
4.3%
Q3 25
4.1%
-11.9%
Q2 25
6.9%
6.9%
Q1 25
4.2%
6.5%
Q4 24
-17.8%
5.4%
Q3 24
-146.7%
-3.3%
Q2 24
-224.4%
8.7%
Q1 24
-207.4%
10.5%
Net Margin
CTEV
CTEV
OEC
OEC
Q4 25
-32.7%
Q3 25
-28.4%
-14.9%
Q2 25
-25.9%
1.9%
Q1 25
-30.8%
1.9%
Q4 24
-59.4%
Q3 24
-169.8%
-4.4%
Q2 24
-247.0%
4.3%
Q1 24
-230.1%
5.3%
EPS (diluted)
CTEV
CTEV
OEC
OEC
Q4 25
$-4.88
$-0.36
Q3 25
$-4.23
$-1.20
Q2 25
$-3.81
$0.16
Q1 25
$-4.38
$0.16
Q4 24
$-8.49
$0.31
Q3 24
$-24.25
$-0.35
Q2 24
$-35.78
$0.35
Q1 24
$-33.40
$0.45

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CTEV
CTEV
OEC
OEC
Cash + ST InvestmentsLiquidity on hand
$16.8M
$60.7M
Total DebtLower is stronger
$4.6B
Stockholders' EquityBook value
$-173.9M
$384.6M
Total Assets
$4.9B
$1.9B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CTEV
CTEV
OEC
OEC
Q4 25
$16.8M
$60.7M
Q3 25
$39.2M
$51.3M
Q2 25
$56.4M
$42.6M
Q1 25
$23.1M
$37.5M
Q4 24
$16.8M
$44.2M
Q3 24
$86.6M
$53.2M
Q2 24
$48.8M
$34.2M
Q1 24
$58.7M
$43.9M
Total Debt
CTEV
CTEV
OEC
OEC
Q4 25
$4.6B
Q3 25
$4.5B
Q2 25
$4.5B
Q1 25
$4.5B
Q4 24
$4.5B
Q3 24
$4.5B
Q2 24
$4.5B
Q1 24
$4.5B
Stockholders' Equity
CTEV
CTEV
OEC
OEC
Q4 25
$-173.9M
$384.6M
Q3 25
$-101.8M
$401.8M
Q2 25
$-39.9M
$466.5M
Q1 25
$14.8M
$466.1M
Q4 24
$84.0M
$474.9M
Q3 24
$207.6M
$476.3M
Q2 24
$603.4M
$503.9M
Q1 24
$1.2B
$492.2M
Total Assets
CTEV
CTEV
OEC
OEC
Q4 25
$4.9B
$1.9B
Q3 25
$5.0B
$2.0B
Q2 25
$5.1B
$2.0B
Q1 25
$5.1B
$2.0B
Q4 24
$5.2B
$1.9B
Q3 24
$5.3B
$2.0B
Q2 24
$5.7B
$1.9B
Q1 24
$6.4B
$1.9B
Debt / Equity
CTEV
CTEV
OEC
OEC
Q4 25
Q3 25
Q2 25
Q1 25
304.87×
Q4 24
53.67×
Q3 24
21.73×
Q2 24
7.48×
Q1 24
3.85×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CTEV
CTEV
OEC
OEC
Operating Cash FlowLast quarter
$66.3M
$92.9M
Free Cash FlowOCF − Capex
$36.4M
$44.2M
FCF MarginFCF / Revenue
14.8%
10.7%
Capex IntensityCapex / Revenue
12.1%
11.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-12.3M
$54.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CTEV
CTEV
OEC
OEC
Q4 25
$66.3M
$92.9M
Q3 25
$19.9M
$68.8M
Q2 25
$61.2M
$53.7M
Q1 25
$-30.1M
$400.0K
Q4 24
$-33.4M
$94.5M
Q3 24
$72.8M
$-30.9M
Q2 24
$18.5M
$29.3M
Q1 24
$49.7M
$32.4M
Free Cash Flow
CTEV
CTEV
OEC
OEC
Q4 25
$36.4M
$44.2M
Q3 25
$-16.3M
$27.9M
Q2 25
$36.6M
$11.5M
Q1 25
$-68.9M
$-28.8M
Q4 24
$-63.8M
$23.5M
Q3 24
$41.1M
$-78.8M
Q2 24
$-7.0M
$-25.4M
Q1 24
$19.2M
$-700.0K
FCF Margin
CTEV
CTEV
OEC
OEC
Q4 25
14.8%
10.7%
Q3 25
-6.6%
6.2%
Q2 25
15.2%
2.5%
Q1 25
-29.8%
-6.0%
Q4 24
-27.5%
5.4%
Q3 24
17.8%
-17.0%
Q2 24
-3.0%
-5.3%
Q1 24
8.2%
-0.1%
Capex Intensity
CTEV
CTEV
OEC
OEC
Q4 25
12.1%
11.8%
Q3 25
14.7%
9.1%
Q2 25
10.2%
9.0%
Q1 25
16.8%
6.1%
Q4 24
13.1%
16.4%
Q3 24
13.8%
10.3%
Q2 24
10.9%
11.5%
Q1 24
13.0%
6.6%
Cash Conversion
CTEV
CTEV
OEC
OEC
Q4 25
Q3 25
Q2 25
5.97×
Q1 25
0.04×
Q4 24
Q3 24
Q2 24
1.43×
Q1 24
1.21×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CTEV
CTEV

Segment breakdown not available.

OEC
OEC

Rubber$272.0M66%
Specialties$139.7M34%

Related Comparisons